Literature DB >> 35862880

Screening for Individuals at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative, Georgia, 2012-2020.

Julia K Veitinger1, Alice S Kerber1, Sheryl G A Gabram-Mendola1, Yuan Liu1, Lynn M Durham1, Diane Durrence1, Alissa K Berzen1, Janet Y Shin1, Cindy Snyder1, Cecelia A Bellcross1, Yue Guan1.   

Abstract

Georgia implemented a statewide family history screening program for hereditary breast and ovarian cancer. From November 2012 through December 2020, 29 090 individuals were screened, 16 679 of whom (57.3%) self-identified as a racial/ethnic minority. Of the 4% (1172/29 090) of individuals who screened as high risk, more than half underwent genetic consultation (793/1172; 67.7%) and testing (416/589; 70.6%). Compared with White women, Black and Hispanic women had higher uptake rates of genetic consultation. Public health settings serving racial minorities are well suited to address disparities in genetic service access. (Am J Public Health. 2022;112(9):1249-1252. https://doi.org/10.2105/AJPH.2022.306932).

Entities:  

Mesh：

Year:  2022        PMID： 35862880      PMCID： PMC9382180          DOI： 10.2105/AJPH.2022.306932

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   11.561


  8 in total

1.  Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.

Authors:  Anne Marie McCarthy; Mirar Bristol; Susan M Domchek; Peter W Groeneveld; Younji Kim; U Nkiru Motanya; Judy A Shea; Katrina Armstrong
Journal:  J Clin Oncol       Date:  2016-05-09       Impact factor: 44.544

2.  Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.

Authors:  Deborah Cragun; Anne Weidner; Courtney Lewis; Devon Bonner; Jongphil Kim; Susan T Vadaparampil; Tuya Pal
Journal:  Cancer       Date:  2017-02-09       Impact factor: 6.860

3.  African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study.

Authors:  Azadeh Stark; Celina G Kleer; Iman Martin; Baffour Awuah; Anthony Nsiah-Asare; Valerie Takyi; Maria Braman; Solomon E Quayson; Richard Zarbo; Max Wicha; Lisa Newman
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

4.  Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.

Authors:  L Brannon Traxler; Monique L Martin; Alice S Kerber; Cecelia A Bellcross; Barbara E Crane; Victoria Green; Roland Matthews; Nancy M Paris; Sheryl G A Gabram
Journal:  Ann Surg Oncol       Date:  2014-07-22       Impact factor: 5.344

5.  Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial.

Authors:  Rena J Pasick; Galen Joseph; Susan Stewart; Celia Kaplan; Robin Lee; Judith Luce; Sharon Davis; Titas Marquez; Tung Nguyen; Claudia Guerra
Journal:  Am J Public Health       Date:  2016-08-23       Impact factor: 9.308

6.  Further development and evaluation of a breast/ovarian cancer genetics referral screening tool.

Authors:  Cecelia Bellcross
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

Review 7.  Initiatives to Scale Up and Expand Reach of Cancer Genomic Services Outside of Specialty Clinical Settings: A Systematic Review.

Authors:  Yue Guan; Colleen M McBride; Hannah Rogers; Jingsong Zhao; Caitlin G Allen; Cam Escoffery
Journal:  Am J Prev Med       Date:  2020-11-07       Impact factor: 5.043

8.  Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study.

Authors:  Tarsha Jones; Anne Marie McCarthy; Younji Kim; Katrina Armstrong
Journal:  Cancer Med       Date:  2017-06-19       Impact factor: 4.452
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.